Intra-Cellular Therapies Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Operating Revenue	1,731	1,725	1,251	1,087	1,024	1,272	Upgrade
Other Revenue	115.23	20.18	-	-	-	-	Upgrade
Revenue	1,846	1,745	1,251	1,087	1,024	1,272	Upgrade
Revenue Growth (YoY)	21.32%	39.52%	15.05%	6.14%	-19.51%	11.77%	Upgrade
Cost of Revenue	1,001	991.06	759.72	677.97	644.66	799.05	Upgrade
Gross Profit	845.24	753.84	490.93	409.13	379.5	473.36	Upgrade
Selling, General & Admin	465.21	441.36	300.1	266.36	244.46	281.18	Upgrade
Other Operating Expenses	124.16	120.7	79.69	75.66	58.99	70.49	Upgrade
Operating Expenses	671.47	639.69	419.33	388.05	353.46	410.96	Upgrade
Operating Income	173.77	114.16	71.6	21.08	26.04	62.4	Upgrade
Interest Expense	-29.76	-29.3	-16.14	-10.05	-9	-9.26	Upgrade
Interest & Investment Income	-	-	8.88	1.41	1.38	1.6	Upgrade
Earnings From Equity Investments	-0.16	-	-	-	-	-0.23	Upgrade
Other Non Operating Income (Expenses)	2.13	6.36	8.88	6.28	4.25	1.35	Upgrade
EBT Excluding Unusual Items	145.97	91.21	73.22	18.73	22.67	55.86	Upgrade
Merger & Restructuring Charges	-	-	-	-16.28	-	-	Upgrade
Gain (Loss) on Sale of Assets	-	-	4.83	0.23	1.89	0.18	Upgrade
Asset Writedown	-	-	-	-25.98	-	-2.17	Upgrade
Other Unusual Items	-	-	1.17	12.65	7.88	6.82	Upgrade
Pretax Income	145.97	91.21	79.22	-10.65	32.44	60.69	Upgrade
Income Tax Expense	6.83	2.71	3.54	2.18	1.99	6.07	Upgrade
Earnings From Continuing Operations	139.14	88.5	75.68	-12.83	30.45	54.62	Upgrade
Earnings From Discontinued Operations	2.91	3.14	2.44	244.71	18.51	-	Upgrade
Net Income to Company	142.05	91.64	78.12	231.88	48.96	54.62	Upgrade
Minority Interest in Earnings	-0.36	-0.95	-0.41	0.58	-0.7	0.99	Upgrade
Net Income	141.69	90.69	77.71	232.46	48.26	55.61	Upgrade
Net Income to Common	141.69	90.69	77.71	232.46	48.26	55.61	Upgrade
Net Income Growth	77.08%	16.70%	-66.57%	381.67%	-13.21%	13.24%	Upgrade
Shares Outstanding (Basic)	61	62	63	64	64	65	Upgrade
Shares Outstanding (Diluted)	63	64	66	65	65	66	Upgrade
Shares Change (YoY)	-1.69%	-2.83%	1.06%	-0.20%	-1.58%	-1.36%	Upgrade
EPS (Basic)	2.31	1.47	1.23	3.65	0.75	0.86	Upgrade
EPS (Diluted)	2.25	1.43	1.19	3.65	0.74	0.84	Upgrade
EPS Growth	81.40%	20.39%	-67.50%	390.36%	-11.31%	15.07%	Upgrade
Free Cash Flow	59.31	27.76	70.58	3.95	48.29	106.89	Upgrade
Free Cash Flow Per Share	0.94	0.44	1.08	0.06	0.74	1.62	Upgrade
Dividend Per Share	0.600	0.600	0.500	1.000	0.350	0.300	Upgrade
Dividend Growth	-	20.00%	-50.00%	185.71%	16.67%	-	Upgrade
Gross Margin	45.78%	43.20%	39.25%	37.64%	37.05%	37.20%	Upgrade
Operating Margin	9.41%	6.54%	5.73%	1.94%	2.54%	4.90%	Upgrade
Profit Margin	7.67%	5.20%	6.21%	21.38%	4.71%	4.37%	Upgrade
Free Cash Flow Margin	3.21%	1.59%	5.64%	0.36%	4.71%	8.40%	Upgrade
EBITDA	255.87	191.79	87.12	42.67	50.34	84.35	Upgrade
EBITDA Margin	13.86%	10.99%	6.97%	3.92%	4.92%	6.63%	Upgrade
D&A For EBITDA	82.1	77.63	15.52	21.59	24.3	21.95	Upgrade
EBIT	173.77	114.16	71.6	21.08	26.04	62.4	Upgrade
EBIT Margin	9.41%	6.54%	5.73%	1.94%	2.54%	4.90%	Upgrade
Effective Tax Rate	4.68%	2.97%	4.47%	-	6.13%	9.99%	Upgrade
Advertising Expenses	-	-	6.17	5.73	4.43	5.32	Upgrade

Updated Nov 6, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.